Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Category: CD as API

March 19, 2026 CD as API / CD derivatives / Pharma applications

Evaluation of the Potential Therapeutic Effects of HPβCD and SBEβCD in a Mouse Model of Acute Ulcerative Colitis

A Nanjing, China based research group designed a tailored investigation [1] based on a surprising previous study [2]. In they

Continue reading

March 18, 2026 CD as API / CD derivatives / Pharma applications

HPBCD accesses acute and subacute infarcts in a mouse model of ischemic stroke

Ischemic stroke is a leading cause of mortality and long-term disability worldwide, with limited pharmacological interventions available. Researchers in Arizona

Continue reading

March 16, 2026 CD as API / Pharma applications

HPαCD Therapy: A Breakthrough for Krabbe Disease Treatment

Several North-American Universities worked together to find hydroxzpropyl-alpha-cyclodextrin(HPaCD) for the treatment of Krabbe disease. The deficiency of β-galactosylceramidase causes a

Continue reading

March 10, 2026 CD as API / CD derivatives / Pharma applications

Toxic effects and cellular uptake of functional polyrotaxanes. The little we have learned and the many unknowns still waiting to be discovered.

Cyclodextrins are commonly used as excipients in modern drug delivery, but they also have a less common role as active

Continue reading

March 2, 2026 CD as API / Pharma applications

Beren Therapeutics’Adrabetadex Received FDA Acceptance for infantile-onset Niemann Pick Disease

Beren Therapeutics Announced FDA Acceptance of its New Drug Application for Adrabetadex in Infantile-Onset Niemann-Pick Disease Type C. Beren Therapeutics

Continue reading

February 23, 2026 CD as API / Pharma applications

The mechanism of ototoxicity studied by using HPBCD

The cochlea is the sensory organ responsible for hearing. Central to its sensory functions is the organ of Corti, a

Continue reading

February 19, 2026 CD as API / Drug delivery / Pharma applications

Enhancing the Water Solubility and Efficacy of Anticancer Drugs Using Hydroxypropyl-β-Cyclodextrin

Previous studies have demonstrated that the solubility and biocompatibility of poorly water-soluble anti-cancer agents can be improved by complexation with

Continue reading

February 9, 2026 CD as API / Drug delivery / Pharma applications

CDs for Regulating Cholesterol Homeostasis in Atherosclerosis

The progression of atherosclerosis (AS) is strongly linked to lipid crystals accumulation caused by cholesterol metabolism disorders and the worsening

Continue reading

February 4, 2026 CD as API / CD derivatives / Pharma applications

Studies on Sleep-Deprived Animals Reveal HPBCD’s Role in Restoring Normal Neuronal Function

A study published in Proceedings of the National Academy of Sciences (https://www.pnas.org/doi/10.1073/pnas.2523438123) suggests that lack of sleep harms the fatty insulation that

Continue reading

January 27, 2026 CD as API / Pharma applications

A water-soluble β-cyclodextrin polymer reduces cholesterol accumulation and autophagy dysfunction in vitro and in Niemann-Pick type C disease model mice

A β-CDP (CycloLab) was used for the experiments. The purity of the β-CDP was >95 %. The β-CDP contained <1 % of

Continue reading

Posts pagination

«Previous Posts 1 2 3 4 … 35 Next Posts»

Recent Posts

  • Call for Chapters: Cyclodextrins in Phytomedicine
  • Poly-CD-PEG-camptothecin Combined with Olaparib  in People With Relapsed/​Refractory Small Cell Lung Cancer (Clinical trial)
  • Alkali Metal Adduct Formation in Cyclic Ion Mobility-Mass Spectrometry of O-Methylated Cyclodextrin Isomers
  • Doxycycline release from cyclodextrin oligomer-containing collagen gels
  • Cyclodextrin-based polymer materials and their applications – A review covering a 20-year period

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (70)
  • CD as API (347)
  • CD derivatives (414)
  • Cosmetics and toilettry (52)
  • Diagnosis (12)
  • Drug delivery (797)
  • E-ducation (63)
  • Environmental (135)
  • Events (234)
  • Food (225)
  • Gene delivery (20)
  • Household products (1)
  • Household products (4)
  • In Hungarian (4)
  • Life sciences (43)
  • Non-pharma applications (403)
  • Other industrial use (107)
  • Pharma applications (1,189)
  • Supramolecular systems (40)
  • Uncategorized (152)

Top Posts

  • Call for Chapters: Cyclodextrins in Phytomedicine
  • Alkali Metal Adduct Formation in Cyclic Ion Mobility-Mass Spectrometry of O-Methylated Cyclodextrin Isomers
  • Poly-CD-PEG-camptothecin Combined with Olaparib  in People With Relapsed/​Refractory Small Cell Lung Cancer (Clinical trial)
  • Cyclodextrins for Chemosensing - Book
  • Call for Book Chapters: Cyclodextrin Systems for Green Hydrogen Production
  • A Cyclodextrin Surprise in a Japanese Supplement
  • Cyclodextrin-based polymer materials and their applications - A review covering a 20-year period
  • GRAS status of CD derivatives
  • Doxycycline release from cyclodextrin oligomer-containing collagen gels
  • Methyl salicylate/methyl-β-cyclodextrin inclusion complex modulates plant defense against cold and heat stress

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,474 other subscribers

Loading Comments...